130 related articles for article (PubMed ID: 34275248)
1. [Effect of gMDSCs on natural killer cell functionality in chronic hepatitis C patients treated with direct-acting antiviral agents].
Shi JJ; Zhou WJ; Lu C; Jia XY; Chang WX; Zhang JY; Li YY; Mu XL
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2133-2139. PubMed ID: 34275248
[No Abstract] [Full Text] [Related]
2. Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir.
Wang XX; Luo BF; Jiang HJ; Cong X; Jin Q; Ma DL; Wei L; Feng B
World J Gastroenterol; 2018 Oct; 24(40):4554-4564. PubMed ID: 30386105
[TBL] [Abstract][Full Text] [Related]
3. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients.
Jiang HJ; Wang XX; Luo BF; Cong X; Jin Q; Qin H; Zhang HY; Kong XS; Wei L; Feng B
Clin Exp Med; 2019 Aug; 19(3):299-308. PubMed ID: 31218578
[TBL] [Abstract][Full Text] [Related]
4. The effects of direct-acting antiviral agents on the frequency of myeloid-derived suppressor cells and natural killer cells in patients with chronic hepatitis C.
Li Y; Zeng Y; Zeng G; Li J; Zhang X; Cai Q; Chen Y; Lin CS
J Med Virol; 2019 Feb; 91(2):278-286. PubMed ID: 30171691
[TBL] [Abstract][Full Text] [Related]
5. Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Bartres C; González P; García-López M; Pose E; Lens S; Maini MK; Forns X; Koutsoudakis G
Front Immunol; 2020; 11():129. PubMed ID: 32161581
[No Abstract] [Full Text] [Related]
6. High frequencies of CD158b+ NK cells are associated with persistent hepatitis C virus infections.
Ji HF; Wang J; Yu L; Niu JQ; Ayana DA; Jiang YF
Ann Hepatol; 2013; 12(4):539-47. PubMed ID: 23813131
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-Acting Antiviral Agents.
Ning G; Li YT; Chen YM; Zhang Y; Zeng YF; Lin CS
Can J Gastroenterol Hepatol; 2017; 2017():3612403. PubMed ID: 28567369
[TBL] [Abstract][Full Text] [Related]
8. [Alteration of CD100 expression on natural killer cells in chronic patients with hepatitis C virus before and after initiation of antiviral treatment].
He Y; Li B; Zhou Y; Zhang Y; Guo Y; Ji G; Fan C; Jia Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):856-60. PubMed ID: 25108441
[TBL] [Abstract][Full Text] [Related]
9. An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.
Kokordelis P; Krämer B; Körner C; Boesecke C; Voigt E; Ingiliz P; Glässner A; Eisenhardt M; Wolter F; Kaczmarek D; Nischalke HD; Rockstroh JK; Spengler U; Nattermann J
Hepatology; 2014 Mar; 59(3):814-27. PubMed ID: 24382664
[TBL] [Abstract][Full Text] [Related]
10. Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.
Serti E; Chepa-Lotrea X; Kim YJ; Keane M; Fryzek N; Liang TJ; Ghany M; Rehermann B
Gastroenterology; 2015 Jul; 149(1):190-200.e2. PubMed ID: 25754160
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients.
Cai W; Qin A; Guo P; Yan D; Hu F; Yang Q; Xu M; Fu Y; Zhou J; Tang X
J Clin Immunol; 2013 May; 33(4):798-808. PubMed ID: 23354838
[TBL] [Abstract][Full Text] [Related]
12. Effect of Direct Acting Antivirals (DAAs) on Myeloid-Derived Suppressor Cells Population in Egyptian Chronic Hepatitis C Virus Patients: A Potential Immunomodulatory Role of DAAs.
Abdulsamad B; Afifi M; Awaad AK; Elbendary W; Mustafa H; Elsherbini B
Viral Immunol; 2023 May; 36(4):259-267. PubMed ID: 36802279
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Ahlenstiel G; Titerence RH; Koh C; Edlich B; Feld JJ; Rotman Y; Ghany MG; Hoofnagle JH; Liang TJ; Heller T; Rehermann B
Gastroenterology; 2010 Jan; 138(1):325-35.e1-2. PubMed ID: 19747917
[TBL] [Abstract][Full Text] [Related]
14. Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.
Serti E; Park H; Keane M; O'Keefe AC; Rivera E; Liang TJ; Ghany M; Rehermann B
Gut; 2017 Apr; 66(4):724-735. PubMed ID: 26733671
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.
Zeng QL; Yang B; Sun HQ; Feng GH; Jin L; Zou ZS; Zhang Z; Zhang JY; Wang FS
Mol Cells; 2014 Jan; 37(1):66-73. PubMed ID: 24552712
[TBL] [Abstract][Full Text] [Related]
16. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
17. Granulocytic myeloid-derived suppressor cell population increases with the severity of alcoholic liver disease.
Gao M; Huang A; Sun Z; Sun Y; Chang B; Zhang JY; Zou ZS
J Cell Mol Med; 2019 Mar; 23(3):2032-2041. PubMed ID: 30585398
[TBL] [Abstract][Full Text] [Related]
18. Restoration of natural killer cell activity by interferon-free direct-acting antiviral combination therapy in chronic hepatitis C patients.
Nakamura I; Furuichi Y; Sugimoto K
Hepatol Res; 2018 Oct; 48(11):855-861. PubMed ID: 29732688
[TBL] [Abstract][Full Text] [Related]
19. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
[TBL] [Abstract][Full Text] [Related]
20. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy.
Lee S; Watson MW; Flexman JP; Cheng W; Hammond T; Price P
J Med Virol; 2010 Apr; 82(4):568-74. PubMed ID: 20166183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
